{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12"],"submitter":["Lasagni S"],"pubmed_abstract":["Background
Though the precise criteria for accessing LT are consistently being applied, HCC recurrence (HCC-R_LT) still affects more than 15% of the patients. We analyzed the clinical, histopathological, and biological features of patients with HCC to identify the predictive factors associated with cancer recurrence and survival after LT.Methods
We retrospectively analyzed 441 patients with HCC who underwent LT in our center. Overall, 70 (15.8%) of them developed HCC-R_LT. We matched them by age at transplant and etiology with 70 non-recurrent patients. A comparable cohort from the Liver Transplant Centre of Bologna served as validation. The clinical and biochemical characteristics and pre-LT criteria (Milan, Metroticket, Metroticket_AFP, and AFP model) were evaluated. Hist"],"journal":["Frontiers in oncology"],"pagination":["960808"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9493368"],"repository":["biostudies-literature"],"pubmed_title":["Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation."],"pmcid":["PMC9493368"],"pubmed_authors":["Gitto S","d'Errico A","Leonardi F","Romagnoli D","Pivetti A","Giannelli G","Romanzi A","Serenari M","Catellani B","Dituri F","Critelli RM","Martinez-Chantar ML","Colecchia A","Celsa C","Mancarella S","di Benedetto F","Camma C","Riefolo M","Lasagni S","Enea M","Di Marco L","Schepis F","Ravaioli F","Milosa F","de Maria N","Cescon M","Villa E","Magistri P"],"additional_accession":[]},"is_claimable":false,"name":"Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation.","description":"Background
Though the precise criteria for accessing LT are consistently being applied, HCC recurrence (HCC-R_LT) still affects more than 15% of the patients. We analyzed the clinical, histopathological, and biological features of patients with HCC to identify the predictive factors associated with cancer recurrence and survival after LT.Methods
We retrospectively analyzed 441 patients with HCC who underwent LT in our center. Overall, 70 (15.8%) of them developed HCC-R_LT. We matched them by age at transplant and etiology with 70 non-recurrent patients. A comparable cohort from the Liver Transplant Centre of Bologna served as validation. The clinical and biochemical characteristics and pre-LT criteria (Milan, Metroticket, Metroticket_AFP, and AFP model) were evaluated. Hist","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-05T12:32:32.945Z","creation":"2025-04-05T12:32:32.945Z"},"accession":"S-EPMC9493368","cross_references":{"pubmed":["36158651"],"doi":["10.3389/fonc.2022.960808"]}}